Results of the NRG Oncology/RTOG 0848 adjuvant chemotherapy question: erlotinib + gemcitabine for resected cancer of the pancreatic head: A Phase II Randomized Clinical Trial

PURPOSE: NRG/RTOG 0848 was designed to determine if adjuvant radiation with fluoropyrimidine sensitization improved survival following gemcitabine-based adjuvant chemotherapy for patients with resected pancreatic head adenocarcinoma. In step 1 of this protocol, patients were randomized to adjuvant g...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Am J Clin Oncol
Main Authors: Abrams, Ross A., Winter, Kathryn A., Safran, Howard, Goodman, Karyn A., Regine, William F., Berger, Adam C., Gillin, Michael T., Philip, Philip A., Lowy, Andrew M., Wu, Abraham, DiPetrillo, Thomas A., Corn, Benjamin W., Seaward, Samantha A., Haddock, Michael G., Song, Suisui, Jiang, Yixing, Fisher, Barbara J., Katz, Alan W., Mehta, Sharmila, Willett, Christopher G., Crane, Christopher H.
Formato: Artigo
Idioma:Inglês
Publicado em: 2020
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7280743/
https://ncbi.nlm.nih.gov/pubmed/31985516
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/COC.0000000000000633
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados